There Is Room To the Upside In Biotech

Today’s trading in biotech and healthcare was rough, once again. However, we did get some long signals for a couple stocks, EVH and FCSC. The later was actually triggered late yesterday but was still active today. Overall, upside potential seems strongest for generic healthcare stocks, but biotech has begun to catch up. Here’s what happened.

Mike Patton
Mike Patton
Mike Patton took the leap into the markets beginning as a commodities broker in 2005, where he was responsible for identifying trading opportunities and executing trades on behalf of clients. After years as a broker he made the jump to education by joining the team at Trading Advantage, now Prosper Trading Academy.